These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 22448662)
1. Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in malignant germ cell tumors of the ovary. Trinh DT; Shibata K; Hirosawa T; Umezu T; Mizuno M; Kajiyama H; Kikkawa F J Obstet Gynaecol Res; 2012 May; 38(5):841-8. PubMed ID: 22448662 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors. Liu A; Cheng L; Du J; Peng Y; Allan RW; Wei L; Li J; Cao D Am J Surg Pathol; 2010 May; 34(5):697-706. PubMed ID: 20410807 [TBL] [Abstract][Full Text] [Related]
3. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Cao D; Guo S; Allan RW; Molberg KH; Peng Y Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406 [TBL] [Abstract][Full Text] [Related]
4. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Cao D; Li J; Guo CC; Allan RW; Humphrey PA Am J Surg Pathol; 2009 Jul; 33(7):1065-77. PubMed ID: 19390421 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. Wang F; Liu A; Peng Y; Rakheja D; Wei L; Xue D; Allan RW; Molberg KH; Li J; Cao D Am J Surg Pathol; 2009 Oct; 33(10):1529-39. PubMed ID: 19574883 [TBL] [Abstract][Full Text] [Related]
6. [Expression and diagnostic significance of OCT4, CD117 and CD30 in germ cell tumors]. Teng LH; Lu DH; Xu QZ; Fu YJ; Yang H; He ZL Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):711-5. PubMed ID: 16536313 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases. Mei K; Liu A; Allan RW; Wang P; Lane Z; Abel TW; Wei L; Cheng H; Guo S; Peng Y; Rakheja D; Wang M; Ma J; Rodriguez MM; Li J; Cao D Mod Pathol; 2009 Dec; 22(12):1628-36. PubMed ID: 19820689 [TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of 2 testicular germ cell markers, Glut3 and CyclinA2. Howitt BE; Brooks JD; Jones S; Higgins JP Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):401-7. PubMed ID: 23343953 [TBL] [Abstract][Full Text] [Related]
9. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas. Ramalingam P; Malpica A; Silva EG; Gershenson DM; Liu JL; Deavers MT Am J Surg Pathol; 2004 Nov; 28(11):1499-505. PubMed ID: 15489654 [TBL] [Abstract][Full Text] [Related]
10. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary. Esheba GE; Pate LL; Longacre TA Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882 [TBL] [Abstract][Full Text] [Related]
11. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cao D; Humphrey PA; Allan RW Cancer; 2009 Jun; 115(12):2640-51. PubMed ID: 19365862 [TBL] [Abstract][Full Text] [Related]
12. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma. Cheng L; Zhang S; Talerman A; Roth LM Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442 [TBL] [Abstract][Full Text] [Related]
13. Expression of CD133 and CD117 in 64 Serous Ovarian Cancer Cases. Stemberger-Papić S; Vrdoljak-Mozetic D; Ostojić DV; Rubesa-Mihaljević R; Krigtofić I; Brncić-Fisher A; Kragević M; Eminović S Coll Antropol; 2015 Sep; 39(3):745-53. PubMed ID: 26898076 [TBL] [Abstract][Full Text] [Related]
14. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Ulbright TM Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467 [TBL] [Abstract][Full Text] [Related]
16. OCT4: a novel biomarker for dysgerminoma of the ovary. Cheng L; Thomas A; Roth LM; Zheng W; Michael H; Karim FW Am J Surg Pathol; 2004 Oct; 28(10):1341-6. PubMed ID: 15371950 [TBL] [Abstract][Full Text] [Related]
17. Role of HNF1β in the differential diagnosis of yolk sac tumor from other germ cell tumors. Rougemont AL; Tille JC Hum Pathol; 2018 Nov; 81():26-36. PubMed ID: 29753846 [TBL] [Abstract][Full Text] [Related]
18. SALL4 is a useful marker for pediatric yolk sac tumors. Wu P; Luo R; Sun B; Zhao J; Xu Q; Feng S; Chen X; Wang C Pediatr Surg Int; 2020 Jun; 36(6):727-734. PubMed ID: 32222813 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of karyopherin 2 in human ovarian malignant germ cell tumor correlates with poor prognosis. He L; Ding H; Wang JH; Zhou Y; Li L; Yu YH; Huang L; Jia WH; Zeng M; Yun JP; Luo RZ; Zheng M PLoS One; 2012; 7(9):e42992. PubMed ID: 22962582 [TBL] [Abstract][Full Text] [Related]